Insider Activity of DiBiase Mary
Biography of DiBiase Mary
No biography is available at this moment.
No biography is available at this moment.
| 2025-01-24 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 22,258 0.0128% | $0.45 | $10,094 | -74.46% | |
| 2024-10-07 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 67,695 0.0345% | $0.57 | $38,329 | -59.93% | |
| 2024-09-09 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 2,642 0.0016% | $0.66 | $1,738 | -52.23% | |
| 2024-03-11 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 15,409 0.0089% | $0.88 | $13,591 | -25.86% | |
| 2024-02-12 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 3,683 0.0022% | $1.01 | $3,709 | -30.62% | |
| 2023-11-01 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 67,695 0.0398% | $0.73 | $49,417 | +9.28% | |
| 2023-09-08 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 2,642 0.0016% | $1.25 | $3,300 | -28.92% | |
| 2023-06-30 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 464 0.0003% | $1.89 | $877 | -49.9% | |
| 2023-06-23 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 857 0.0006% | $1.93 | $1,654 | -50.18% | |
| 2023-06-15 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 857 0.0006% | $2.23 | $1,911 | -56.59% | |
| 2023-03-10 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 18,192 0.0118% | $0.84 | $15,281 | +9.83% | |
| 2023-02-13 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 4,348 0.0029% | $0.93 | $4,044 | +3.7% | |
| 2022-08-17 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 1,713 – | $0 | $0 | +16.38% | |
| 2022-06-30 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 1,578 – | $0 | $0 | +21.24% | |
| 2022-06-24 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 856 – | $0 | $0 | +8.88% | |
| 2022-06-16 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 856 – | $0 | $0 | +6.54% | |
| 2022-02-11 | Sale | X4 Pharmaceuticals, Inc. XFOR | Chief Operating Officer | 12,545 0.0362% | $1.52 | $19,068 | -21.79% |